STANDARD BIOTOOLS INC. files 425

— Standard BioTools Inc. is acquiring Treeline Biosciences, Inc. in an all-stock merger. The deal values Treeline at $2.5 billion and Standard BioTools at $460 million, subject to adjustments based on Standard BioTools' net cash at closing. Following the merger, former Standard BioTools stockholders are expected to own approximately 16% of the combined company, and former Treeline stockholders are expected to own approximately 84%. (2) DEAL TERMS —